Inozyme Pharma Inc. - Multiplikator EV/Sales INZY

Logo perusahaan publik Inozyme Pharma Inc. (INZY)

Adherence to ESG standards obligates Inozyme Pharma, Inc. (INZY) to minimize its environmental footprint during production. A strategic alliance with clinics is accelerating vascular therapy trials, while the leadership's R&D authority strengthens the issuer's position. This EV/Sales trend, provided by the GURU.Markets website, demonstrates the market valuation of the business, where the indicator determines the magnitude of the company's enterprise value-to-revenue metric.

Inozyme Pharma - Rasio nilai perusahaan marang pendapatan INZY (periode 04.07.2022 - 20.11.2026)

Inozyme Pharma Inc. - rincian analitis lan metrik utama (INZY)

Analisis wiwitan perusahaan:Inozyme, INZY
Produk seri Inozyme Pharma

Professional selection of resilient assets requires benchmarking market capitalization and net debt against sales volume to avoid overpaying for a business. By analyzing the EV/Sales ratio, an investor assesses the enterprise value relative to revenue, which is critical for Inozyme Pharma, Inc. (INZY), where binary clinical trial risks and biomanufacturing costs drive valuation volatility and capital requirements.

Analisis pesaing

Nilai bisnis marang pendapatan VRTX (Vertex Pharmaceuticals)|ALNY: Multiplikator EV/Sales|Insmed Inc. (INSM) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan United Therapeutics Corp.|BMRN: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan bridgebio.com (BBIO)|Multiplikator EV/Sales BGM Group (BGM)|Multiplikator EV/Sales COGT (cogentbio.com)|Multiplikator EV/Sales Xeris Biopharma Inc XERS|KROS - Rasio nilai perusahaan marang pendapatan|ARCT - Multiplikator EV/Sales|ETON (Eton Pharma) - Nilai perusahaan marang pendapatan|kamada.com (KMDA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Fulcrum Therapeutics, Inc.|Multiplikator nilai perusahaan marang pendapatan abeonatherapeutics.com ABEO|Multiplikator EV/Sales MREO|Multiplikator EV/Sales Protalix BioTherapeutics, Inc (PLX)|Rasio nilai perusahaan marang pendapatan pliantrx.com PLRX|Rasio total nilai perusahaan marang pendapatan Applied Therapeutics, Inc. (APLT)|RNTX: Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Gelteq Ltd (GELS)|AYTU: Multiplikator EV/Sales|Chemomab Therapeutics Ltd (CMMB) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan SRx Health Solutions Inc.|Multiplikator nilai perusahaan marang pendapatan polyrizon-biotech.com PLRZ|Nilai perusahaan marang pendapatan AEZS (zentaris.com)|CYTH - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Reneo Pharma RPHM|Aeterna Zentaris - Rasio nilai perusahaan marang pendapatan